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CObjectives: To examine the performance of instrumental variables (IV)
and ordinary least squares (OLS) regression under a range of conditions
likely to be encountered in empirical research. Methods: A series of sim-
ulation analyses are carried out to compare estimation error between OLS
and IV when the independent variable of interest is endogenous. The
simulations account for a range of situations that may be encountered by
researchers in actual practice—varying degrees of endogeneity, instru-
ment strength, instrument contamination, and sample size. The intent of
this article is to provide researchers with more intuition with respect to
how important these factors are from an empirical standpoint. Results: O
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oi:10.1016/j.jval.2011.06.009otably, the simulations indicate a greater potential for inferential error
hen using IV than OLS in all but the most ideal circumstances. Conclu-
ions: Researchers should be cautious when using IV methods. These
ethods are valuable in testing for the presence of endogeneity but only
nder the most ideal circumstances are they likely to produce estimates
ith less estimation error than OLS.
eywords: bias, endogeneity, instrumental variables.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
There is considerable interest in the potential application of in-
strumental variable (IV) techniques in the field of outcomes re-
search. In large part, this can be traced back to the increased de-
mand for real-world evidence regarding treatment effectiveness,
safety, and value on the part of payer organizations and regulatory
authorities. For example, the comparative effectiveness research
component of health reform in the United States is specifically
focused on understanding comparative treatment effectiveness
and safety in actual clinical practice.
In any real-world analysis, there are a variety of conditions that can
leadtobiasedestimates. Inthevernacularofeconometrics, thesecanall
be classified under the general concept of endogeneity. In the simplest
terms, endogeneity is defined as a nonzero correlation between an ex-
planatory variable xj and the disturbance term u of a regression equa-
tion. Such a correlation can be generated by a wide variety of sources,
including omitted variables, measurement error, incorrect functional
form, simultaneity, sample selection bias, and various combinations of
these problems (note that endogeneity is similar to the concept of con-
founding in the field of epidemiology [1]). Endogeneity is a source of
concern because, by definition, its presence means that parameter es-
timates from ordinary least squares (OLS) will be biased and inconsis-
tent (see for example [2]). Moreover, the sources that generate it nearly
always exist in studies involving observational data. To make matters
* Address correspondence to: William Crown, OptumInsight Life S
E-mail: bill.crown@innovus.com.
098-3015/$36.00 – see front matter Copyright © 2011, Internation
ublished by Elsevier Inc.worse, the researcher never knows how big the endogeneity problem is
in any particular study because the disturbance term u is unobserved
and, as a consequence, so is the extent of the correlation between the
endogenous variable xj and u.
Given its importance, it is not surprising that the topic of endogene-
ty has long been a central topic in the econometrics literature. IV ap-
roaches for addressing the problem of endogeneity date to the 1920s—
lthoughthe identityof the inventorremains indoubtandwillprobably
ever be established for certain [3]. Early applications of IV focused on
he estimation of supply and demand curves in agricultural markets.
conomists typically observed only market clearing prices and quanti-
ies. Consequently, they needed statistical methods that would enable
hem to estimate the separate demand and supply relationships under-
ying markets. The IV approach relies on finding at least one variable
hat is correlated with the endogenous variable but uncorrelated with
he outcome. In the case of estimating supply and demand for agricul-
uralproducts, thismeantcomingupwithvariables thatwererelatedto
emand but not supply (e.g., income), as well as those that were related
o supply but not demand (e.g., weather conditions). With more than
ine decades to accumulate, the theoretical and applied literature on IV
stimation is vast [4].
In outcomes research applications, IV estimation methods are
ost often used to help address problems of sample selection bias.
ample selection bias arises when there are unmeasured variables
hat influence both treatment selection and outcomes. Failure to
ces, 950 Winter Street, Suite 3800, Waltham, MA, USA.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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1079V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 7 8 – 1 0 8 4account for these unmeasured variables results in biased esti-
mates of treatment effects because the parameter estimate of the
treatment variable also reflects the effects of the missing variables
on outcomes. Conceptually, the objective of the IV approach is to
estimate a model of treatment selection as a function of a set of
independent, nonendogenous variables. At least one of these vari-
ables needs to be correlated with treatment selection but uncor-
related with the outcome variable. Because treatment is modeled
as a function of nonendogenous variables, the predicted values of
treatment from the model are, by construction, not correlated
with the residuals of the outcome equation. Hence, by substituting
the predicted values of the treatment variable for the original val-
ues when estimating the treatment effect in the outcome model
the endogeneity problem has been solved and it is possible to
obtain unbiased estimates of the treatment effect. However, the
success of the IV approach hinges critically on the properties of the
instrumental variables identified as being correlated with treat-
ment selection but uncorrelated with the outcome variable.
One of the seminal papers on the use of IV methods in out-
comes research is by McClellan et al. [5]. In that study the authors
created a variable that indicated if the nearest hospital treated
acute myocardial infarction admissions with cardiac catheteriza-
tion. This assumed that distance was related to the treatment
setting where patients received care but was unrelated to out-
comes itself. Numerous other articles have subsequently used dis-
tance as an IV in outcomes studies [6–9]. Aside from distance,
other IVs have included differential physician payment amounts
associated with different treatments [6], relative time on market
as an instrument for diffusion of knowledge to physicians about
alternative treatments [10], out-of-pocket copayments for alterna-
ive pharmaceutical products [11], and many others. In each of
these studies, there was reason to expect that the results of stan-
dard OLS regression estimates would be biased by endogeneity. In
each instance, the authors were able to identify an IV that was
correlated with the explanatory variable of interest and assumed
to be uncorrelated with the disturbance term of the outcome equa-
tion. But the fact that the IV estimates may have differed from the
OLS results doesn’t necessarily mean that the IV estimates were
less biased. As we demonstrate empirically in this article using
simulation methods, the relative unbiasedness and estimation er-
ror of IV and OLS hinges critically on a number of factors, including
the strength of the instrument and the degree to which the instru-
ment still retains some correlation with the error term of the out-
come equation. Larger sample sizes make the distinction between
the properties of IV and OLS under various conditions more appar-
ent but do not fundamentally change conclusions about the rela-
tive merits of the two estimators under a given set of conditions.
Despite the appeal of IV methods for addressing the many vari-
ants of endogeneity that commonly arise in the analysis of
observational data, researchers have raised concerns over the per-
formance of IV and parametric sample selection bias models—
noting, in particular, the practical problems often encountered in
identifying good instruments, sensitivity of instruments to as-
sumptions about functional form [12], and general lack of under-
standing of the statistical properties of IV in nonlinear models
(except for the handful of cases where these properties have been
established). It is remarkably difficult to come up with strong in-
struments (i.e., variables that are highly correlated with the en-
dogenous variable) that are uncorrelated with the disturbance
term. As a result, instruments tend to be either weakly correlated
with the variable for which they are intended to serve as an instru-
ment, correlated with the disturbance term, or both.
Staiger and Stock [13] note that empirical evidence on the
strength of instruments is sparse. In their review of 18 articles
published in the American Economic Review between 1988 and 1992
using two-stage least squares, none reported first stage F statistics
or partial R2s measuring the strength of identification of the in-truments. Although not reported in the original studies, Ebbes
14] found considerable variability in the strength of instruments
sed by researchers in the returns to education literature [15,16].
ore recently, researchers have been more likely to report statis-
ics related to instrument strength and contamination. For exam-
le, several articles in the health services research area have re-
orted on the strength of the instruments used [5,9,10].
Although it is impossible to draw any systematic conclusions from
his handful of examples, it is safe to assume that 1) IV methods will
ften generate different conclusions than standard regression models
hat do not attempt to control for endogeneity; 2) the strength of instru-
ents used in various studies varies widely; and 3) instruments are
ften correlated with the disturbance term of the outcome equation.
n fact, we argue that in an effort to minimize the correlation of the
nstrument with the disturbance term, researchers will have a ten-
ency to identify weak instruments.
In general, the more highly an instrument is correlated with the
ndogenous variable, the more likely that the instrument is also cor-
elated with the unobservable u [17]. Consider a simple linear model
here the outcome variable y is a linear function of a treatment
ariable x, a parameter  and an unobservable error term e1:
yx e1, where E(e1)  0. (1)
Suppose also that the treatment variable x is, in turn, a function of
another variable z, a parameter   0 and an unobservable e2
(assumed to be uncorrelated with the error term of the outcome
equation e1:
 z e2 where E(z e1)  0, E(e2)  E(z e2)  0 (2)
Suppose also that (e1,e2)  0. The presence of e2 in the determi-
ation of x gives rise to the endogeneity problem through its cor-
elation with e1. Assuming it is measurable, the variable
 ze2 (3)
rises as a natural choice of instrumental variable for x. The
strength” of the instrument v may be expressed by its correlation
ith x, (v,x). Comparing equations (2) and (3) the strongest pos-
ible instrument for x is x itself (i.e., (x,v)  1 when   1). How-
ver, because (e1,e2)  0, the instrument is only “uncontami-
nated” (i.e., (v,e1)  0) when   0, and furthermore, the level of
contamination is increasing in . In other words, the two desirable
haracteristics of a “good” instrument (strong covariance with the
ndogenous explanatory variable and no correlation with the un-
bservable) seem to be inherently in tension. The reason that
trong instruments and clean instruments are not theoretically
ncompatible is that, in addition to its covariance with e1, e2 con-
ains a random component  that is uncorrelated with e1.
Based on the above, it is reasonable to expect that researchers
ould gravitate toward the use of weak instruments to reduce the
hance of using an instrument that is itself endogenous. Several
tudies, however, have shown that weak instruments may lead
ot only to larger standard errors in treatment estimates but may,
n fact, lead to estimates that have larger bias than OLS [13,18–20].
n particular, Bound et al. [18] show that the incremental bias of IV
ersus OLS is inversely proportional to strength of the instrument
nd the number of excluded variables. In this article we investi-
ate if the Bound et al. [18] results give rise to practical concerns for
empirical researchers by simulating how bias in an IV estimator is
related to the strength of the correlation between the instrument
and the variable that it is intended to replace. We also examine
how bias in the IV estimator is related to the strength of the cor-
relation between the instrument and the observed residuals (the
contamination of the instrument). Finally, rather than considering
C
u
W
w
b
m
a
m
t
n
t
e
s
t
s
s
d
p
a
s
i
C
a
a
t
t
l
p
1080 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 7 8 – 1 0 8 4the behavior of these estimators in the limit, we examine how bias
changes in relation to sample size for a range of study sizes more
likely to be encountered in practice.
Methods
In the next section we present the results of a simulation study
to demonstrate estimation error caused from correlation be-
tween the disturbance term and the IV when sample selection
models are employed to estimate regression parameters in the
presence of an endogenous explanatory variable. In what fol-
lows, we assume the purpose of the analysis is to estimate the
average treatment effect. There has been considerable discus-
sion in the literature about what is meant by treatment effects—
particularly when there is heterogeneity in response to treat-
ment (see for example [21]). For the purposes of the simulations
presented in this article, average treatment effects are assumed
not to be heterogeneous. By average treatment effects we mean
the difference in expected outcomes (shift in the constant term)
when the treatment dummy T is 1 versus 0. T is a determined by
a latent treatment selection model:
x 0 T 1
else T 0
where x  e2.
onsider a model of outcome, y, as a function of treatment, T and an
nobservable e1
y01T	 where 	 e1.
e also construct an instrumental variable, z, which, ideally,
ould be correlated with T, but not with e1.
We generate a trivariate normal variance covariance distri-
ution (e1,e2,z) where e1 are the residuals from the outcome
equation, e2 are the residuals from the treatment selection
equation, and z is the instrumental variable. For illustrative
purposes, we set the covariance of the residuals in the outcome
and treatment selection equations at. This strikes us intuitively
as a substantial level of endogeneity for the purposes of the
simulations. Next, we set the correlation of the instrument with
treatment selection to be either 0.5 (a “strong” instrument) or
0.25 (a “weak” instrument). Note that, for the purposes of the
simulations, it is necessary only to define instruments that are
strong and weak in a relative sense. Our strong instrument is
defined to have twice the correlation with treatment than the
weak instrument. In practice, defining strong and weak instru-
ments is generally based upon the significance of the parameter
estimates in the first stage equation relating the instruments to
treatment. However, aside from statistical significance, some
instruments may be much stronger than others. We wish to
simulate the effect of using relatively stronger instruments ver-
sus weaker instruments to address a given level of endogeneity
(Baiocchi et al. [22] discuss the tradeoff between instrument
strength and sample size. They find that using observations at
the two extremes of the excess travel time distribution by dis-
carding the middle observations considerably strengthens ex-
cess travel time as an instrument. This effect outweighs the loss
of sample size). We then allow the correlation between the in-
strument and unobservable to vary across a range of values.
This allows us to assess the effects of remaining endogeneity if
the instrument is not completely independent of the residuals.
Finally, outcomes y are generated, given (e1,e2,z), with true val-
ues 0  6 of and 1  1 .
We model the covariances among the errors as trivariate nor-
al because this conforms to the majority of the literature on IV
nd sample selection models. The literature on sample selection
odels generally assumes an OLS model with a normal distribu-ion for the residuals in the outcome equation (1) and a cumulative
ormal probability distribution for the error distribution in equa-
ion (2).
The number of replicate studies was chosen [23] to be large
nough to illustrate the effects of alternative assumptions about
trength of endogeneity, strength of the instrument, correlation of
he instrument with the residuals of the outcome equation, and
ample size. Because treatment is a binomial variable we can use
tandard power tables to estimate the required sample size to
etect alternative effect sizes in the treatment estimates. A sam-
le size of 1000 is sufficient to detect effect sizes of 20% or larger at
99% confidence level with a 97% power. Two previous important
imulation articles in the field chose the number of replicate stud-
es to be 500 [24] and 1000 [25].
The analyses were programmed using Stata 8.2 (200x, Stata
orp, College Station, TX).
Results
The strong instrument case
In the strong instrument case, we find that differences in the mean
estimation error (i.e., bias) (IV – *) – (OLS – *) increase linearly
as the contamination of the instrument (i.e., 	z) increases, with an
intercept approximately equal to 	T.(
	/
T)  0.4 and slope
pproximately equal to (1/Tz).(
	/
T)  5 consistent with the re-
sults of Bound et al. [18]. Note that the mean estimation error of
the IV estimator equals or exceeds the mean estimation error of
the OLS estimator (i.e., is 0) approximately when 	z Tz · 	T
0.08 (see Fig. 1).
It is important to note that this result with respect to bias is
only part of the story. This is because neither asymptotic nor av-
erage performance of the IV estimator relative to OLS necessarily
reflects performance for a particular study with a finite sample
size. To illustrate this fact, we plot the distribution of estimation
errors from 1000 replicate studies, each with a sample size of n 
2000, for three levels of instrument contamination: 	z  0.0, 0.08
nd 0.16 (see Fig. 2).
With this relatively large sample size, the sampling distribu-
ions of the OLS and IV estimators have small standard errors and
he distributions do not overlap. IV outperforms OLS (i.e., has
ower estimation error) in 1000 out of 1000 replicate studies with a
erfectly clean instrument (	z  0). Conversely, OLS outperforms
IV in 1000 out of 1000 replicate studies with a very contaminated
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Fig. 1 – Mean estimation error as a function of z.instrument (	z 0.16). Furthermore, even though the IV estimator
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distributions was nearly two and a half times that for the OLS
estimator (0.106 vs. 0.043, 0.104 vs. 0.043, and 0.106 vs. 0.043, for
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we note that the sign of the OLS estimation error is consistently
positive, while the IV estimation error is sometimes positive and
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1082 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 7 8 – 1 0 8 4sometimes negative. As a result, it is not possible to have a expec-
tation about the direction of bias with IV when the IV is not com-
pletely exogenous.
The convergence of IV performance relative to OLS at various
levels of instrument contamination can be clearly visualized by plot-
ting the probability that IV is outperformed by OLS (i.e., the percent of
the 1000 replicate studies in which |(IV – *)| – |(OLS – *)|  0 as the
ample size of each replicate increases (Fig. 3). (Technically, these are
stimated relative frequencies rather than probabilities because they
re generated by replicate samples rather than actual population). The
symptotic results indicate that all lines below 0.08 will eventually ap-
roach zero, whereas all lines above 0.08 will eventually approach one.
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Fig. 4 – Mean estimation error as a function of z.
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Estimation ErrorFig. 5 – Distribution of estimatioAsymptotic results do not necessarily indicate better perfor-
ance in any particular study until sample size is relatively
arge— even for fairly uncontaminated instruments. For exam-
le, with a relatively uncontaminated instrument (	z  0.06),
the probability that IV is outperformed by OLS in any given
study remains as high as 25% for n  1000 and is still over 15%
for n  2000.
The weak instrument case
We next consider the case of a weaker instrument in which the
correlation between z and the endogenous latent selection vari-
able, x, equals the correlation between x and the unobservable, 	
i.e., xz  0.25 and 	x  0.25). We note that even this weaker
nstrument is fairly strong relative to the magnitude of the endo-
eneity problem, say, in comparison to the classic study by Angrist
nd Krueger [26] in which birth quarter served as an instrument
or educational attainment in an estimate of the effect of educa-
ion on weekly earnings.
We again find a linear relationship between the difference in
ean estimation error (IV – *) – (OLS – *) and the contamina-
tion of the instrument (i.e., 	z), with IV estimation bias exceeding
LS estimation bias approximately when 	z  Tz · 	T 0.04 (see
ig. 4). In comparison to Figure 1, the relationship displayed in
igure 4 has a slope twice as steep, due to the halving of Tz,
whereas the intercept remains the same.
We next demonstrate that finite sample performance of the IV
estimator relative to OLS can deviate even further from asymp-
totic results when the instrument is relatively weak. We again plot
the distribution of estimation error from 1000 replicate studies,
each with a sample size of n 2000, for three levels of instrument
contamination: 	z  0.0, 0.04 and 0.08 (see Fig. 5), noting that the
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1083V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 7 8 – 1 0 8 4levels of instrument contamination chosen are now exactly half
the levels in the strong instrument case.
With a sample size of n 2000, we find simulated finite sample
erformance that is not as close as when the instrument was
trong (see Fig. 5).
The distributions of the OLS and IV estimation errors are no-
iceably more dispersed than in the strong instrument case. OLS,
owever, still outperforms IV (i.e., has lower estimation error) in
9 out of 1000 replicate studies, even with a perfectly clean instru-
ent (	z  0). With a sample size of 2000 for each replicate, the
atio of the standard deviation of IV estimation errors to the standard
eviation of OLS estimation errors has settled to approximately five to
ne (0.215 vs. 0.043, 0.212 vs. 0.043, and 0.219 vs. 0.043, for 	z 0.0, 0.04,
nd 0.08, respectively). In other words, at these sample sizes, the ratio of
he standard deviation of IV estimation errors to the standard deviation
f OLS estimation errors approximately doubles when the strength of
he instrument is cut in half.
This result leads us to expect slower convergence of the estimators’
elative performance to their asymptotic results. Again, we plot the
robability that IV is outperformed by OLS (i.e., the percent of the 1000
eplicate studies in which |(IV –*)| –|(OLS –*)|0) as the sample size of
each replicate increases (Fig. 6).
That the bias of IV is lower than that of OLS for instruments
with contamination levels 0  	z  0.04 says little about relative
performance of the methods in a particular study until sample size
is quite large. Even with a perfectly uncontaminated instrument
(	z  0), the probability that IV is outperformed by OLS in any
iven study remains over 20% for n as large as 1000. For a very
lightly contaminated instrument (	z  0.02), OLS still outper-
formed IV in nearly 20% of the studies, even with n  2000.
Conclusions
There is a large econometrics literature using simulation methods
to evaluate the empirical properties of alternative estimators.
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Fig. 6 – Probability |(However, to our knowledge there are no studies comparing OLSand IV under alternative assumptions regarding instrument
strength, sample size, degree of the endogeneity problem, and
correlation of the instruments with the residuals in the outcome
equation. The simulation results reported in this article are in-
tended to provide empirical estimates of the magnitude of estima-
tion error under various conditions using the theoretical frame-
work of Bound et al. [18] as the guiding structure. The intent of this
article was to provide researchers with more intuition around how
important these issues are from an empirical standpoint. In par-
ticular, it is rare to see discussion of the potential effects of instru-
ment contamination in the applied health econometrics litera-
ture. Rather common, on the other hand, are heroic attempts to
“find an instrument” whenever the slightest possibility of endoge-
neity arises.
Although the appeal of IV as a method for addressing endog-
eniety issues is undeniable, it is important to understand that the
use of IV can do more harm than good. In fact, the simulations
indicate a greater potential for inferential error when using IV
than OLS in all but the most ideal circumstances. We have shown
that even the sobering asymptotic results of Bound et al. [18], dem-
onstrating the maximally acceptable level of contamination for an
instrument relative to both the instrument’s strength and the se-
riousness of the endogeneity problem, are perhaps not sobering
enough. In actual empirical work, finite sample sizes affect the
variance of the distribution of estimation errors and this is com-
pounded when the instrument is weak. For the size of samples
used in most studies, the probability that IV is outperformed by
OLS is substantial, even when the asymptotic results indicate bias
to be lower for IV.
Unfortunately, just as we can never know the true magni-
tude of the endogeneity problem to begin with, we can never
know exactly how contaminated our instrument really is (both
quantities depend on the unobservable residuals of the out-
come equation). We do, however, have the ability to measure
the correlation of our instrument with observed treatment se-
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1084 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 7 8 – 1 0 8 4the empirical residuals relative to the unobserved 	 we can cer-
tainly test for endogeneity, contamination of the instrument,
and instrument strength. Brookhart et al. [27] provide an excel-
ent set of practical recommendations for conducting and re-
orting IV analyses.
Perhaps less widely recognized, it is possible to infer the
ikely direction of the bias in OLS estimates due to the presence
f correlated unobservables (that we can often name but cannot
easure). Based upon the simulation results, we note that the
ean of the estimated sampling distribution for OLS was con-
istently greater than the known parameter value being esti-
ated. As a result, the direction of bias from OLS is consistently
ositive and it can be assumed that the bias from OLS is posi-
ive. On the other hand, the mean of the sampling distribution
or IV was sometimes greater than the known parameter value
nd sometimes less. As a result, the direction of bias with IV
hen the instrument is correlated with the residuals cannot be
etermined a priori.
This seems like a fairly important piece of information to
ive up.
We urge caution in using IV methods in treatment effects re-
ression at even the merest suggestion of endogeneity. If it is pos-
ible to identify and construct a plausible instrument, there may
ell be value in using IV as a test for the presence of endogeneity.
esearchers should recognize that they will need to find a strong
nstrument and it will need to have a very low correlation with the
mpirical residuals. And they should make sure that they have a
arge sample.
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